scholarly article | Q13442814 |
P50 | author | Loredana Ciuclan | Q114737335 |
Jafar Hamzavi | Q114737430 | ||
Rainer Heuchel | Q42353151 | ||
P2093 | author name string | Steven Dooley | |
Patricio Godoy | |||
Honglei Weng | |||
Peter R Mertens | |||
Sabrina Ehnert | |||
P2860 | cites work | A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues | Q70859629 |
Suppression of antioxidative enzyme expression by transforming growth factor-beta 1 in rat hepatocytes | Q71625217 | ||
Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts | Q73746119 | ||
Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFbeta signal transduction during transdifferentiation of hepatic | Q74292004 | ||
Smad7: a new key player in TGF-beta-associated disease | Q74486070 | ||
Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis | Q79333602 | ||
The antifibrotic effect of TGF-beta1 siRNAs in murine model of liver cirrhosis | Q83034940 | ||
??? | Q28140333 | ||
Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3 | Q24550794 | ||
Mechanisms of TGF-beta signaling from cell membrane to the nucleus | Q27860785 | ||
Smad7 is induced by CD40 and protects WEHI 231 B-lymphocytes from transforming growth factor-beta -induced growth inhibition and apoptosis | Q28139074 | ||
Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542 | Q28204648 | ||
Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes | Q28238030 | ||
New insights into TGF-beta-Smad signalling | Q28260517 | ||
Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets | Q28303698 | ||
Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells | Q28571744 | ||
Liver fibrosis | Q29547449 | ||
TGF-beta signaling and the fibrotic response | Q29620099 | ||
Critical role of Smads and AP-1 complex in transforming growth factor-beta -dependent apoptosis | Q33913785 | ||
Apoptosis in podocytes induced by TGF-beta and Smad7 | Q36041187 | ||
Anti-TGF-beta strategies for the treatment of chronic liver disease | Q36339566 | ||
Inhibition of ALK5 as a new approach to treat liver fibrotic diseases | Q36455336 | ||
In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis | Q36553502 | ||
Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2. | Q37257648 | ||
Expression of Smads during in vitro transdifferentiation of hepatic stellate cells to myofibroblasts | Q38301076 | ||
Transforming growth factor-beta-induced apoptosis is mediated by Smad-dependent expression of GADD45b through p38 activation | Q38351218 | ||
IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads | Q40204600 | ||
Upregulation of two BH3-only proteins, Bmf and Bim, during TGF beta-induced apoptosis | Q40243666 | ||
Deletion of exon I of SMAD7 in mice results in altered B cell responses. | Q40278136 | ||
Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury | Q40757687 | ||
Liver fibrogenesis due to cholestasis is associated with increased Smad7 expression and Smad3 signaling | Q41890914 | ||
Modulation of transforming growth factor beta function in hepatocytes and hepatic stellate cells in rat liver injury | Q41893786 | ||
Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation | Q42160419 | ||
Role of cytochrome P-450 2E1 in ethanol-, carbon tetrachloride- and iron-dependent microsomal lipid peroxidation | Q42455526 | ||
Conditional tetracycline-regulated expression of TGF-β1 in liver of transgenic mice leads to reversible intermediary fibrosis | Q44419371 | ||
Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats | Q44507331 | ||
Involvement of mitochondria in acetaminophen-induced apoptosis and hepatic injury: roles of cytochrome c, Bax, Bid, and caspases | Q44567499 | ||
Long-term treatment with insulin induces apoptosis in brown adipocytes: role of oxidative stress. | Q44590737 | ||
Source of early reactive oxygen species in the apoptosis induced by transforming growth factor-beta in fetal rat hepatocytes | Q44734271 | ||
Genomic locus and promoter region of rat Smad7, an important antagonist of TGFbeta signaling | Q47887730 | ||
Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways. | Q51926243 | ||
Multiple roles of mouse Numb in tuning developmental cell fates. | Q52133869 | ||
P433 | issue | 5B | |
P304 | page(s) | 2130-2144 | |
P577 | publication date | 2008-02-04 | |
P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
P1476 | title | Disruption of the Smad7 gene enhances CCI4-dependent liver damage and fibrogenesis in mice | |
P478 | volume | 12 |